Sign inJoin waitlistJoin the waitlist

Conor Steuer

Physician · Emory University School of Medicine

Credentials: · · · ·

History

Emory University School of Medicine
Present

Hematology and Medical Oncology
Emory University School of Medicine
2012–2015
Internal Medicine
Emory University School of Medicine
2009–2012
New York University
2005–2009

Research

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
The Lancet Oncology · 2020 · 1,363 citations
An update on larynx cancer
Review · Current Anthropology · 2017 · First of 5 authors · 577 citations
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
Review · Annals of Oncology · 2018 · 273 citations

Nabil Saba
58 papers
Suresh Ramalingam
42 papers
Dong Shin
36 papers
Taofeek Owonikoko
35 papers
Mihir Patel
26 papers · 1 as a fellow
Kristin Higgins
23 papers
RP
Rathi Pillai
20 papers
FK
Fadlo Khuri
19 papers
Mark McDonald
18 papers
William Stokes
18 papers
JB
Jonathan Beitler
17 papers
Nicole Schmitt
15 papers

Clinical trials

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Principal investigator · Recruiting · Phase 2
Emory University
2024–2029
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Principal investigator · Completed · Phase 1
Sirnaomics
2021–2024
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
Principal investigator · Recruiting · Phase 1
Emory University
2021–2026
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
Principal investigator · Active not recruiting · Phase 1
Emory University
2018–2027